Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1045 of 1,261

  1. US 7465815

    Cannabinoid receptor modulator

    Takeda Pharmaceutical Company Limited · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

  2. US 7465738

    Compounds useful as promoters of SMN2

    Vertex Pharmaceuticals Incorporated · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

  3. US 7465449

    Anti-αvβ6 antibodies

    The Regents of the University of California · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

  4. US 7462603

    Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery

    The Regents of the University of California · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  5. US 7462743

    Polymorphs of memantine hydrochloride

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  6. US 7462737

    Pregabalin free of isobutylglutaric acid and a process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  7. US 7462635

    Thiazole and oxazole VDAC regulator

    Takeda Pharmaceutical Company Limited · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  8. US 7462609

    Narcistatin prodrugs

    THE ARIZONA BOARD OF REGENTS · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  9. US 7462625

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  10. US 7462628

    Preventives/remedies for urinary disturbance

    Takeda Pharmaceutical Company Limited · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  11. US 7462345

    Radionuclide labeling of vitamin B12 and coenzymes thereof

    Regents of the University of Minnesota · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  12. US 7462691

    Mouse prostate stem cell antigen and uses thereof

    The Regents of the University of California · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  13. US 7462356

    Chimeric papillomavirus-like particles

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  14. US 7462612

    Pyridine inhibitors of ERK2 and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  15. US 7459439

    Granulysin peptides and methods of use thereof

    The Regents of the University of California · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted

  16. US 7459426

    Methods of using IL-1 antagonists to treat autoinflammatory disease

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted

  17. US 7459453

    Pyridazin-3(2H)-one derivatives as PDE4 inhibitors

    Laboratories Almirall, S.A. · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted

  18. US 7459156

    Antibodies that mimic actions of neurotrophins

    The Regents of the University of California · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted

  19. US 7459534

    Inactivation resistant factor VIII

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted

  20. US 7459536

    HGF-SF monoclonal antibody combinations

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted

  21. US 7459462

    Fredericamycin derivatives

    Biofrontera Discovery GmbH · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted

  22. US 7459601

    Human α synuclein expressing transgenic mice

    The Regents of the University of California · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted

  23. US 7459458

    Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

    Neurocrine Biosciences, Inc. · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted

  24. US 7455994

    Methods for producing Marburg virus proteins

    The United States of America as represented by the Secretary of the Army · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.